Allianz Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-6,032,141
Closed -$4.09M 2646
2015
Q1
$4.09M Sell
6,032,141
-4,704
-0.1% -$3.29K ﹤0.01% 1293
2014
Q4
$4.77M Sell
6,036,845
-102,569
-2% -$70.1K 0.01% 1236
2014
Q3
$2.85M Buy
6,139,414
+183,562
+3% +$89.1K ﹤0.01% 1302
2014
Q2
$2.98M Buy
5,955,852
+2,110,867
+55% +$1.02M ﹤0.01% 1068
2014
Q1
$1.23M Sell
3,844,985
-688,131
-15% -$256K ﹤0.01% 1348
2013
Q4
$1.54M Sell
4,533,116
-209,538
-4% -$253K ﹤0.01% 1283
2013
Q3
$9.58M Sell
4,742,654
-65,611
-1% -$125K 0.01% 689
2013
Q2
$9.28M Buy
+4,808,265
New +$8.45M 0.01% 661

Other funds holding GCVRZ

Allianz Asset Management's GCVRZ Position: Q2 2015 in Review

Allianz Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2015, closing a stake of 6,032,141 shares — an estimated $4.09M sold.

Allianz Asset Management first reported a position in GCVRZ in Q2 2013 and held it in 8 quarters. The position peaked at $9.58M in Q3 2013. 116 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2015.

  • Allianz Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q2 2015 after selling out during the quarter.
  • Allianz Asset Management sold 6,032,141 Sanofi Contingent Value Rights shares in Q2 2015, an estimated $4.09M.
  • Allianz Asset Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 8 quarters.
  • Allianz Asset Management's Sanofi Contingent Value Rights position peaked at $9.58M in Q3 2013.
  • 116 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2015.

Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.